Company Valuation: West Pharmaceutical Services, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 34,744 17,424 26,053 23,723 19,795 24,361 - -
Change - -49.85% 49.53% -8.95% -16.56% 23.07% - -
Enterprise Value (EV) 1 34,744 16,738 25,406 23,441 19,206 23,858 23,322 22,903
Change - -51.82% 51.78% -7.74% -18.07% 24.22% -2.25% -1.8%
P/E 54.1x 30.4x 44.7x 49x 40.5x 40.4x 35.1x 31.4x
PBR 14.9x 6.5x 8.98x 8.83x 5.95x 7.78x 6.79x 6.01x
PEG - -2.8x 23.04x -3.2x 27.09x 1.5x 2.3x 2.6x
Capitalization / Revenue 12.3x 6.04x 8.83x 8.2x 6.44x 7.22x 6.79x 6.32x
EV / Revenue 12.3x 5.8x 8.61x 8.1x 6.25x 7.07x 6.5x 5.94x
EV / EBITDA 39.3x 19x 30.7x 32.2x 24.2x 25.4x 22.4x 19.8x
EV / EBIT 45.6x 22x 36.8x 40.9x 30.9x 31.5x 27.5x 24x
EV / FCF 105x 38.1x 61.3x 84.8x 41x 55.4x 41.1x 31.6x
FCF Yield 0.95% 2.63% 1.63% 1.18% 2.44% 1.8% 2.43% 3.17%
Dividend per Share 2 0.69 0.74 0.78 0.82 0.85 0.9025 0.9729 1.121
Rate of return 0.15% 0.31% 0.22% 0.25% 0.31% 0.26% 0.28% 0.32%
EPS 2 8.67 7.73 7.88 6.69 6.79 8.575 9.865 11.04
Distribution rate 7.96% 9.57% 9.9% 12.3% 12.5% 10.5% 9.86% 10.2%
Net sales 1 2,832 2,887 2,950 2,893 3,074 3,375 3,587 3,854
EBITDA 1 884.7 882.6 827.9 728.2 793.8 940.4 1,041 1,159
EBIT 1 762.4 762 690.6 572.8 622.4 757.5 848.4 952.3
Net income 1 661.8 585.9 593.4 492.7 493.7 614.5 701.2 778
Net Debt 1 - -685.4 -647.1 -282 -588.5 -503.3 -1,039 -1,458
Reference price 2 469.01 235.35 352.12 327.56 275.14 346.16 346.16 346.16
Nbr of stocks (in thousands) 74,080 74,033 73,990 72,422 71,943 70,376 - -
Announcement Date 17/02/22 16/02/23 15/02/24 13/02/25 12/02/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
31.92x4.3x16.65x2.31% 193B
20.52x3.56x12.5x3.28% 116B
16.98x0.2x12.29x0.77% 59.16B
32.4x8.09x20.64x1.23% 55.75B
35.07x3.39x11.63x2.16% 49.57B
36.67x6.45x20.26x-.--% 34.52B
46.3x1.32x12.04x0.16% 31.22B
40.37x7.07x25.37x0.26% 24.36B
20.68x3.14x11.72x1.4% 24.25B
Average 31.21x 4.17x 15.90x 1.29% 65.26B
Weighted average by Cap. 29.41x 4.06x 15.47x 1.86%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. WST Stock
  4. WPS Stock
  5. Valuation West Pharmaceutical Services, Inc.